Brick & Kyle, Associates - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Brick & Kyle, Associates ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2017$33,000
+50.0%
275
+37.5%
0.03%
+44.4%
Q4 2016$22,000
-18.5%
2000.0%0.02%
-18.2%
Q3 2016$27,000
+50.0%
2000.0%0.02%
+46.7%
Q2 2016$18,000
+28.6%
2000.0%0.02%
+25.0%
Q1 2016$14,0000.0%2000.0%0.01%0.0%
Q4 2015$14,000
-22.2%
2000.0%0.01%
-29.4%
Q3 2015$18,000
-28.0%
2000.0%0.02%
-19.0%
Q2 2015$25,000
+38.9%
2000.0%0.02%
+40.0%
Q1 2015$18,000
-10.0%
200
-33.3%
0.02%
-11.8%
Q4 2014$20,0003000.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders